![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Changes in the characteristics of hepatitis
C patients treated with direct-acting antivirals from 2014-2017
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting, November 9-13, 2018, San Francisco, CA
Amanda W. Singer1, Krystin Matthews2, Anu Osinusi1, Diana M. Brainard1, Laura Telep1, Anand P. Chokkalingam1
1Gilead Sciences, Foster City, CA; 2The University of Texas Health Sciences Center at Houston, School of Public Health, Austin, TX
![1113181](../images%20/111318/111318-19/1113181.gif)
![1113182](../images%20/111318/111318-19/1113182.gif)
![1113183](../images%20/111318/111318-19/1113183.gif)
![1113184](../images%20/111318/111318-19/1113184.gif)
![1113185](../images%20/111318/111318-19/1113185.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|